Energy- generating enzymes of Burkholderia cepacia and their interactions with macrophages

Journal of Bacteriology

Volumn 185, Issue 10, 2003, Pages 3167-3178

  Punj, Vasu ^a   Sharma, Rachna ^a   Zaborina, Olga ^a   Chakrabarty, A M ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTIBODY; AZURIN; AZURIN ANTIBODY; BACTERIAL ENZYME; CYTOCHROME C; CYTOCHROME C ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CELL DEATH; CYSTIC FIBROSIS; CYTOTOXICITY; DENITRIFICATION; ELECTRON TRANSPORT; ENERGY TRANSFER; FRACTIONATION; MACROPHAGE; MAST CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; AZURIN; BACTERIAL PROTEINS; BURKHOLDERIA CEPACIA; CASPASES; CELLS, CULTURED; CLONING, MOLECULAR; CYSTEINE PROTEINASE INHIBITORS; CYSTIC FIBROSIS; CYTOCHROME C GROUP; ENERGY METABOLISM; MACROPHAGES; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; SEQUENCE HOMOLOGY, AMINO ACID; TOXICITY TESTS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0038643174     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.185.10.3167-3178.2003     Document Type: Article

References (60)

1. Adrian, C., and S. J. Martin. 2001. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem. 26:390-397.
2. Bevivino, A., C. Dalmastri, S. Tabaechioni, L. Chiarini, M. L. Bell, S. Piana, A. Materazzo, P. Vandamme, and G. Manno. 2002. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J. Clin. Microbiol. 40:846-851.
3. Coenye, T., P. Vandamme, and J. J. LiPuma. 2002. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg. Infect. Dis. 8:692-696.
4. Dangas, E., D. Nochy, L. Ravagnan, and M. Loeffler. 2000. Apoptosisinducing factor (AIF): ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 476:118-123.
5. Daubaras, D. L., C. E. Danganam, A. Hubner, R. W. Ye, W. Hendrickson, and A. M. Chakrabarty. 1996. Biodegradation of 2,4,5-trichlorophenoxyacetic acid by Burkholderia cepacia strain AC1100: evolutionary insight. Gene 179:1-8.
6. Decatur, A. L., and D. A. Portnoy. 2000. A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity. Science 290:992-995.
7. Deveraux, Q. L., E. Leo, H. R. Stennick, K. Welch, G. S. Salvesen, and J. C. Reed. 1999. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18:5242-5251.
8. Dhanabal, M., R. Ramchandran, M. J. F. Waterman, H. Lu, B. Knebelmann, M. Segal, and V. P. Sukhatme. 1999. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274:1721-11726.
9. Gounaris, K., S. Thomas, P. Najarro, and M. E. Selkirk. 2001. Secreted variant of nucleoside diphosphate kinase from the intracellular parasitic nematode Trichinella spiralis. Infect. Immun. 69:3658-3662.
10. Gounaris, K. 2002. Nucleotidase cascades are catalyzed by secreted proteins of the parasitic nematode Trichinella spiralis. Infect. Immun. 70:4917-4924.
11. Govan, J. R., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
12. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
13. Holmes, A., J. Govan, and R. Goldstein. 1998. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg. Infect. Dis. 4:221-227.
14. Hutchison, M. I., I. R. Poxton, and J. R. W. Govan. 1998. Burkholderia cepacia produces a hemolysin that is capable of inducing degranulation and apoptosis in mammalian phagocytes. Infect. Immun. 66:2033-2039.
15. Jones, A. M., M. E. Dodd, and A. K. Webb. 2001. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur. Respir. J. 17:295-301.
16. Kohler, C., A. Gahm, T. Noma, A. Nakazawa, S. Orrenius, and B. Zhivotovsky. 1999. Release of adenylate kinase 2 from mitochondrial intermembrane space during apoptosis. FEBS Lett. 447:10-12.
17. Kroemer, G. 1997. Mitochondrial implication in apoptosis: towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ. 4:443-456.
18. Kukimoto, M., M. Nishiyama, M. Tanokura, M. E. Murphy, E. T. Adman, and S. Horinouchi. 1996. Site directed mutagenesis of azurin from Pseudomonas aeruginosa enhances the formation of an electron-transfer complex with a copper-containing nitrite reductase from Alcaligenes faecalis S-6. FEBS Lett. 394:87-90.
19. Lagatolla, C., S. Skerlavaj, L. Dolzani, E. A. Tonin, C. MontiBragadin, M. Bosco, R. Rizzo, L. Giglo, and P. Cascutti. 2002. Microbiological characterization of Burkholderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced. FEMS Microbiol. Lett. 209:99-106.
20. Lessie, T. G., and T. Gaffney. 1986. Catabolic potential of Pseudomonas cepacia, p. 439-481. In J. R. Sokatch and L. N. Ornston (ed.), The bacteria, vol. 10: the biology of Pseudomonas. Academic Press, Orlando, Fla.
21. LiPuma, J. J. 1998. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr. Opin. Pulmon. Med. 4:337-341.
22. LiPuma, J. J., and E. Mahenthiralingam. 1999. Commercial use of Burkholderia cepacia. Emerg. Infect. Dis. 5:305-306.
23. LiPuma, J. J., T. Spilker, T. Coenye, and C. F. Gonzalez. 2002. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359:2002-2003.
24. Liu, L., T. Coenye, J. L. Burns, P. W. Whitby, T. L. Stull, and J. J. LiPuma. 2002. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 40:1210-1213.
25. Liu, S., N. Ogawa, and K. Miyashita. 2001. The chlorocatechol degradative genes, tfdT-CDEF, of Burkholderia sp. strain NK 8 are involved in chlorobenzoate degradation and induced by chlorobenzoates and chlorocatechols. Gene 268:207-214.
26. Mahenthiralingam, E., M. Campbell, D. Henry, and D. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920.
27. Mahenthiralingam, E., T. Coenye, J. W. Chung, D. P. Speert, J. R. W. Govan, P. Taylor, and P. Vandamme. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:910-913.
28. Mahenthiralingam, E., A. Baldwin, and P. Vandamme. 2002. Burkholderia cepacia complex infection in patients with cystic fibrosis. J. Med. Microbiol. 51:533-538.
29. Markaryan, A., O. Zaborina, V. Punj, and A. M. Chakrabarty. 2001. Adenylate kinase as a virulence factor of Pseudomonas aeruginosa. J. Bacteriol. 183:3345-3352.
30. Marolda, C. L., B. Hauroder, M. A. John, R. Michel, and M. A. Valvano. 1999. Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae. Microbiology 145: 1509-1517.
31. Martin, D. W., and C. D. Mohr. 2000. Invasion and intracellular survival of Burkholderia cepacia. Infect. Immun. 68:24-29.
32. May, T. B., and A. M. Chakrabarty. 1994. Pseudomonas aeruginosa: genes and enzymes of alginate biosynthesis. Trends Microbiol. 2:152-157.
33. Melnikov, A., O. Zaborina, N. Dhiman, B. S. Prabhakar, A. M. Chakrabarty, and W. Hendrickson. 2000. Clinical and environmental isolates of Burkholderia cepacia exhibit differential cytotoxicity towards macrophages and mast cells. Mol. Microbiol. 36:1481-1493.
34. Mignotte, B., and J. L. Vayssiere. 1998. Mitochondria and apoptosis. Eur. J. Biochem. 252:1-15.
35. Miramar, M. D., P. Costantini, L. Ravagnan, L. M. Suraiva, G. Brothers, J. M. Penninger, M. L. Peleato, G. Kromer, and S. A. Susin. 2001. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem. 276:16391-16398.
36. Pervaiz, S., M. A. Sayed, J. L. Hirpara, M. Clement, and K. W. Loh. 1999. Purified photoproducts of merocyanine 540 trigger cytochrome c release and caspase dependent apoptosis in human leukemia and melanoma cells. Blood 93:4096-4108.
37. Pier, G. B. 1998. Pseudomonas aeruginosa: a key problem in cystic fibrosis. ASM News 64:339-347.
38. Punj, V., and A. M. Chakrabarty. 2003. Redox proteins in mammalian cell death: an evolutionarily conserved function in mitochondria and prokaryotes. Cell. Microbiol., 5:225-231.
39. Punj, V., O. Zaborina, N. Dhiman, K. Falzari, M. Bagdasarian, and A. M. Chakrabarty. 2000. Phagocytic cell killing mediated by secreted cytotoxic factors of Vibrio cholerae. Infect. Immun. 68:4930-4937.
40. Richau, J. A., J. H. Leitao, M. Correia, L. Lito, M. J. Salgado, C. Barreto, P. Cescutti, and I. Sa-Correia. 2000. Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center. J. Clin. Microbiol. 38:1651-1655.
41. Saini, L. S., S. B. Galsworthy, M. A. John, and M. A. Valvano. 1999. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145:3465-3475.
42. Salvesen, G. S., and V. M. Dixit. 1997. caspases: intracellular signaling by proteolysis. Cell 91:443-446.
43. Shields, M. S., M. J. Reagin, R. R. Gerger, R. Campbell, and C. Somerville. 1995. TOM, a new aromatic degradative plasmid from Burkholderia cepacia (Pseudomonas cepacia G4). Appl. Environ. Microbiol. 61:1352-1356.
44. Single, B., M. Leist, and P. Nicotera. 1998. Simultaneous release of adenylate kinase and cytochrome c in cell death. Cell Death Differ. 5:1001-1003.
45. Speert, D. P., M. Bond, R. C. Woodman, and J. T. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. 170:1524-1531.
46. Stennicke, H. R., and G. S. Salvesen. 1999. caspases: preparation and characterization. Comp. Methods Enzymol. 17:313-319.
47. Suzuki, K., N. Ogawa, and K. Miyashita. 2001. Expression of 2-halobenzoate dioxgenease genes (cbdABC) involved in the degradation of benzoate and 2-halobenzoate in Burkholderia cepacia sp. TH2. Gene 262:137-145.
48. Tamas, I., L. Klasson, B. Canback, A. K. Nashund, A. S. Eriksson, J. J. Wernegreen, J. P. Sandstrom, N. A. Moran, and S. G. Andersson. 2002. 50 million years of genomic stasis in endosymbiotic bacteria. Science 296:2376-2379.
49. Tettelin, H., V. Masignani, M. J. Cieslewicz, J. A. Eisen, S. Peterson, M. R. Wessels, et al. 2002. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. USA 99:12391-12396.
50. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
51. Vairano, M., C. D. Rusoo, G. Pozzoli, A. Battaglia, G. Scambia, G. Tringali, M. A. Aloe-spirit, P. Preziosi, and P. Navarra. 2002. Erythropoetin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur. J. Neurosci. 16: 584-592.
52. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
53. Vandamme, P., E. Mahenthiralingam, B. Holmes, T. Coenye, B. Hoste, P. De Vos, D. Henry, and D. P. Speert. 2000. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J. Clin. Microbiol. 38:1042-1047.
54. Vandamme, P., D. Henry, T. Coenye, S. Nzula, and M. Vancanneyt. 2002. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol. Med. Microbiol. 33:143-149.
55. 551 and nitrite reductase. Eur. J. Biochem. 194:109-118.
56. Welling, G. W., W. J. Weijer, R. Van der Zee, and S. Welling-Webster. 1985. Prediction of sequential antigenic regions in proteins. FEBS Lett. 188:215-218.
57. Yamada, T., M. Goto, V. Punj, O. Zaborina, K. Kimbara, T. K. Das Gupta, and A. M. Chakrabarty. 2002. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect. Immun. 70:7054-7062.
58. Zaborina, O., N. Misra, J. Kostal, S. Kamath, V. Kapatral, M. El-Azami El-Idrissi, B. S. Prabhakar, and A. M. Chakrabarty. 1999. P2Z-independent and P2Z receptor-mediated macrophage killing by Pseudomonas aeruginosa isolated from cystic fibrosis patients. Infect. Immun. 67:5231-5242.
59. Zaborina, O., N. Dhiman, M. L. Chen, J. Kostal, I. A. Holder, and A. M. Chakrabarty. 2000. Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor- mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiology 146:2521-2530.
60. Zhou, X. M., B. C. Wong, X. M. Fan, H. B. Zhang, M. C. Lin, H. F. Kung, D. M. Fan, and S. K. Lam. 2001. Nonsteroidal anti-inflammatory drugs induce apoptosis in gastric cells through regulation of Bax and Bak. Carcinogenesis 22:1393-1397.